| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |